Daniel Abdun-Nabi - Aug 3, 2016 Form 4/A - Amendment Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
Director
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Stock symbol
APVO
Transactions as of
Aug 3, 2016
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/7/2023, 03:38 PM
Date Of Original Report
Aug 5, 2016
Next filing
Jun 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APVO Common Stock 41.8K Aug 3, 2016 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares has been adjusted to reflect the correct number of shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016. On March 26, 2020, the Issuer effected a reverse stock split at a ratio of 1-for-14, resulting in every 14 shares owned by the reporting person to be combined into one share of common stock, thus reducing the number of shares owned by the reporting person to 4,173 as of March 26, 2020.